About Us

about

Overview

Founded in 2005, SonarMed® is a privately-held medical device company that uses sound-based technologies to solve healthcare problems. SonarMed developed the AirWave™ Airway Monitoring System to solve critical airway management challenges, thereby addressing an enormous unmet need in critical care and the operating room. AirWave provides continuous, real-time endotracheal tube monitoring and is indicated for both neonatal/pediatric and adult use. It is the only FDA cleared airway monitoring system for patients who can’t breathe on their own.

The AirWave technology was initially developed at Purdue University by SonarMed founders Dr. Jeffrey Mansfield, Dr. Eduardo Juan, and Dr. George Wodicka, using the principles of acoustic reflectometry to develop a more comprehensive approach for the management of endotracheal tubes.

Development of AirWave was supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) and the Indiana 21s t Century Research and Technology Fund.

Leadership Team

  • Tom Bumgardner, CEO

    Experienced senior executive and entrepreneur with successful experience in start-ups to Fortune 20 companies. Managed P&Ls and budgets of $25MM to $500MM in high growth and turnaround environments. MBA from the University of Texas at Austin.

  • David Gunn, CFO

    Successful entrepreneur and sales and marketing professional with significant product launch, channel strategy, vendor and distribution management experience. Co-founder of three successful start-ups and former PricewaterhouseCoopers consultant. MBA from Cornell University.

  • Jeff Mansfield, PhD, CTO, Founder

    Expert in biomedical acoustics with 20 years in medical device R&D. Formerly a Senior Research Scientist and Systems Engineer at Cardiac Science. PhD and MS from Purdue University.

  • Tom Larkin, EVP Commercialization

    Experienced medical device sales executive who drove more than $150MM in annual sales for Eli Lily’s ACS (Guidant) unit after launching his career at SpaceLabs. Has held multiple CXO level positions including Chief Sales Officer, where he raised $6+ billion dollars of new investment funds.

  • Laura Lyons, VP of Compliance and Respiratory Care

    A leading FDA “trouble shooter” with significant senior experience in regulatory, quality, and FDA relations at Roche, Abbott, Beckman-Coulter. Began her career as a Respiratory Therapist. Allied Health degree in Respiratory Therapy from The University of Texas Health Science Center at Houston (UTHealth) and BS in Business Administration from University of Phoenix.

  • Sven Schreiber, Director of Operations

    Management roles in manufacturing and Quality Assurance at 3M and Aventis Pharmaceuticals. Six Sigma Greenbelt certified with experience in Lean Manufacturing. BS from Purdue University.

  • Laura Withers, MBA, Director of Clinical Services

    Experienced respiratory therapy consultant with more than 15 years of experience. Previously served as a clinical supervisor at MD Anderson Cancer Center. MBA from Texas Woman’s University and BS in Respiratory Care Therapy from The University of Texas Medical Branch at Galveston.